The Sami-Sabinsa Group, a global leader in the nutraceutical and cosmeceutical industries, has appointed Dr. Devaraj Reddy as its new chief operating officer.
Dr. Reddy brings extensive experience in managing cross-functional operations across multiple sites. His expertise includes developing innovative strategies for manufacturing and quality operations within the nutraceuticals, functional foods, and cosmeceuticals sectors. He has a proven track record in research related to the production of standardized herbal extracts and synthetic molecules for B2B product requirements in global markets.
In his new role, Dr. Reddy will be based at the Sami-Sabinsa Group’s corporate office in Peenya. He will oversee the heads of all manufacturing facilities, production, operations, exports, and commercial activities. Additionally, he will coordinate closely with other departments to ensure cohesive alignment across the organization.
Shaheen Majeed, Sabinsa’s global managing director and CEO, expressed confidence in Dr. Reddy’s appointment: “The Sami-Sabinsa Group has grown and become increasingly more global, so it’s important to have structure and oversight to support our continued expansion with focus on production, process improvements, and quality. Dr. Devaraj’s scientific background coupled with business experience is an excellent fit for the Sami-Sabinsa Group. His strategic oversight will be pivotal in driving our organizational growth and operational excellence.”
Dr. Reddy’s combination of scientific expertise and business acumen is expected to play a crucial role in the Sami-Sabinsa Group’s ongoing growth and success.
